Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy
Wei Yuan, Qiyi Zhao, Zhiliang Gao, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 8, pp. 3347-3360
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Tumor-Associated Macrophages in Tumor Immunity
Yueyun Pan, Yinda Yu, Xiaojian Wang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 1354
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
Hirohito Yamaguchi, Jung-Mao Hsu, Wenhao Yang, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 5, pp. 287-305
Closed Access | Times Cited: 334
The role of exosomal PD-L1 in tumor progression and immunotherapy
Feiting Xie, Mengxue Xu, Jian Lu, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 293
Programmed death ligand 1 signals in cancer cells
Anand Kornepati, Ratna K. Vadlamudi, Tyler J. Curiel
Nature reviews. Cancer (2022) Vol. 22, Iss. 3, pp. 174-189
Open Access | Times Cited: 268
Regulation of PD-L1 Expression by NF-κB in Cancer
Fabrizio Antonangeli, Ambra Natalini, Marina Chiara Garassino, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 251
Current status of immune checkpoint inhibitors for gastric cancer
Koji Kono, Shotaro Nakajima, Kosaku Mimura
Gastric Cancer (2020) Vol. 23, Iss. 4, pp. 565-578
Open Access | Times Cited: 193
The Good and the Bad: Monocytes’ and Macrophages’ Diverse Functions in Inflammation
Judith Austermann, Johannes Roth, Katarzyna Barczyk‐Kahlert
Cells (2022) Vol. 11, Iss. 12, pp. 1979-1979
Open Access | Times Cited: 106
Anaplastic Thyroid Carcinoma: An Update
Arnaud Jannin, Alexandre Escande, Abir Al Ghuzlan, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 1061-1061
Open Access | Times Cited: 90
Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes
Aleksandr Zaitsev, Maksim Chelushkin, Daniiar Dyikanov, et al.
Cancer Cell (2022) Vol. 40, Iss. 8, pp. 879-894.e16
Open Access | Times Cited: 86
Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma
Zhuo Yu, Yuyao Li, Yue Li, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 5, pp. e004297-e004297
Open Access | Times Cited: 77
PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma
Ligong Lu, Zhiling Zhou, Xu-Yan Wang, et al.
Gut (2022) Vol. 71, Iss. 12, pp. 2551-2560
Open Access | Times Cited: 72
Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy
Safir Ullah Khan, Munir Ullah Khan, Muhammad Azhar Ud Din, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 55
Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy
Yelee Kim, Jiwoong Choi, Eun Hye Kim, et al.
Advanced Science (2024) Vol. 11, Iss. 22
Open Access | Times Cited: 20
HKDC1 promotes tumor immune evasion in hepatocellular carcinoma by coupling cytoskeleton to STAT1 activation and PD-L1 expression
Yi Zhang, Mingjie Wang, Ling Ye, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma
Gang Xiao, Li-Lian Jin, Chaoqun Liu, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 146
Highly Multiplexed Phenotyping of Immunoregulatory Proteins in the Tumor Microenvironment by CODEX Tissue Imaging
Darci J. Phillips, Christian M. Schürch, Michael S. Khodadoust, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 92
Antigen presentation by lung epithelial cells directs CD4+ TRM cell function and regulates barrier immunity
Anukul T. Shenoy, C. Lyon De Ana, E.I. Arafa, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 87
Manipulating the function of tumor-associated macrophages by siRNA-loaded lipid nanoparticles for cancer immunotherapy
Nour Shobaki, Yusuke Sato, Yuichi Suzuki, et al.
Journal of Controlled Release (2020) Vol. 325, pp. 235-248
Closed Access | Times Cited: 84
NF-κB and Its Role in Checkpoint Control
Annika Betzler, Marie‐Nicole Theodoraki, Patrick J. Schuler, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3949-3949
Open Access | Times Cited: 74
Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function
Amy J. Petty, Rui Dai, Rosa Lapalombella, et al.
JCI Insight (2021) Vol. 6, Iss. 6
Open Access | Times Cited: 73
PD-L1 Is Expressed and Promotes the Expansion of Regulatory T Cells in Acute Myeloid Leukemia
Yuqing Dong, Yixiang Han, Yisha Huang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 72
PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages
Yukiko Yamaguchi, Jackson Gibson, Kevin Ou, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004400-e004400
Open Access | Times Cited: 61
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer
Seok‐Beom Yong, Srinivas Ramishetti, Meir Goldsmith, et al.
Advanced Materials (2022) Vol. 34, Iss. 13
Open Access | Times Cited: 44
Inhibition of the VEGF signaling pathway attenuates tumor‑associated macrophage activity in liver cancer
Shohei Okikawa, Yuji Morine, Yu Saito, et al.
Oncology Reports (2022) Vol. 47, Iss. 4
Open Access | Times Cited: 43
Nasopharyngeal cancer cell‐derived exosomal PD‐L1 inhibits CD8+ T‐cell activity and promotes immune escape
Jie Yang, Jierong Chen, Hu Liang, et al.
Cancer Science (2022) Vol. 113, Iss. 9, pp. 3044-3054
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top